U.S. flag An official website of the United States government
  1. Home
  2. News & Events
  3. FDA Meetings, Conferences and Workshops
  4. Public Calendar - Meetings With FDA Officials
  5. Public Calendar: October 8-14, 2023
  1. Public Calendar - Meetings With FDA Officials

Public Calendar: October 8-14, 2023

This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the federal government.

Official Name: Robert M. Califf, M.D., MACC, Commissioner for Food and Drugs

Event Date: 10/08/2023
Location: Washington, DC
Subject: National Academies of Medicine 2023 Annual Meeting: Women's Health: From Cells to Society; Panelist: Revolutionizing Women's Health: Envisioning a New Era of Progress, Policy, and Research
FDA Participant/Group: N/A
Non FDA Participant/Group: Industry, government, academia, and media

Event Date: 10/09/2023
Location: Virtual
Subject: 35th Annual Laguna Biotech CEO Forum; Speaker: Keynote Address
FDA Participant/Group: N/A
Non FDA Participant/Group: Industry

Event Date: 10/10/2023
Location: Chicago, IL
Subject: Journal of the American Medical Association (JAMA) Summit - Is the Clinical Trials Enterprise Broken and How Can It Be Fixed?
FDA Participant/Group: N/A
Non FDA Participant/Group: Industry, government, and academia

Event Date: 10/10/2023
Location: Virtual
Subject: 2023 FDA Omics Day; Speaker: Opening Remarks
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Industry, government, and academia

Event Date: 10/10/2023
Location: Chicago, IL
Subject: Reagan Udall-Foundation Evidence Generation Medical Products Experts Panel Meeting
FDA Participant/Group: HILARY MARSTON; ALI ABBASI;
Non FDA Participant/Group: Industry, academia, and government

Event Date: 10/11/2023
Location: Washington, DC
Subject: Friends of Cancer Research's 27th Annual Cancer Leadership Awards
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Industry, academia, and government

Official Name: Janet Woodcock, M.D., Principal Deputy Commissioner

No Significant Event

Official Name: Jim Jones, Deputy Commissioner for Human Foods

Event Date: 10/11/2023
Location: Washington, DC
Subject: Trust for America's Health - The State of Obesity: Creating Pathways to a Healthier America; Panelist
FDA Participant/Group: N/A
Non FDA Participant/Group: Industry, academia, government, and media

Event Date: 10/12/2023
Location: College Park, MD
Subject: Introductory Meeting
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: David Chavern, Mara Burr, Sarah Gallo, Stacy Papadopoulos (Consumer Brands Association);

Event Date: 10/13/2023
Location: Virtual
Subject: Introductory Meeting
FDA Participant/Group: LARRY MORRIS;
Non FDA Participant/Group: Joe Reardon, Ted McKinney (National Association of State Departments of Agriculture);

Event Date: 10/13/2023
Location: Virtual
Subject: Introductory Meeting
FDA Participant/Group: JEFFREY FARRAR; KARI BARRETT; CATHERINE MCDERMOTT; MARK MOORMAN; JULIE MOSS;
Non FDA Participant/Group: Gabriele Ludwig, Julie Adams, Keith Schneller, Tim Birmingham (The Almond Board of California);

Event Date: 10/13/2023
Location: Virtual
Subject: Introductory Meeting
FDA Participant/Group: LARRY MORRIS;
Non FDA Participant/Group: Leslie Sarasin (Food Industry Association);

Official Name: Kimberlee Trzeciak, Deputy Commissioner for Policy, Legislation, and International Affairs

Event Date: 10/12/2023
Location: Washington, DC
Subject: U.S. - India Health Dialogue; Speaker: FDA Regulation Functions
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Government, regulatory, and Indian senior government representatives

Official Name: Jim Sigg, Deputy Commissioner for Operations

No Significant Event

Official Name: Mark Abdoo, Associate Commissioner for Global Policy and Strategy

No Significant Event

Official Name: Michael Rogers, Acting Associate Commissioner for Regulatory Affairs

Event Date: 10/11/2023
Location: Virtual
Subject: Introductory Meeting
FDA Participant/Group: N/A
Non FDA Participant/Group: Jennifer Trodden (New York State Department of Agriculture and Markets);

Official Name: Leah Hunter, Associate Commissioner for External Affairs

No Significant Event

Official Name: Namandjé N. Bumpus, Ph.D., Chief Scientist

Event Date: 10/10/2023
Location: Silver Spring, MD
Subject: Introductory Meeting
FDA Participant/Group: N/A
Non FDA Participant/Group: Ewa King, Scott Becker, Shari Shea (Association of Public Health Laboratories);

Official Name: Patrizia Cavazzoni, M.D., Director, Center for Drug Evaluation and Research

Event Date: 10/10/2023
Location: Virtual
Subject: Sponsor Meeting Processes
FDA Participant/Group: N/A
Non FDA Participant/Group: Frank Sasinowski (Hyman, Phelps, and McNamara (HPM));

Event Date: 10/11/2023
Location: Virtual
Subject: Best Practices
FDA Participant/Group: SARAH MCMULLEN; GREGORY SMITH; THERESA MULLIN;
Non FDA Participant/Group: Rajeev Raghuvanshi, S. Manivannan, Santosh Indraksha (Central Drugs Standard Control Organization (CDSCO));

Event Date: 10/13/2023
Location: Virtual
Subject: Listening Session
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Various members of the American Brain Coalition

Official Name: Peter Marks, M.D., Ph.D., Director, Center for Biologics Evaluation and Research

Event Date: 10/11/2023
Location: Virtual
Subject: COVID-19 Vaccine Education and Equity Project/National Foundation for Infectious Diseases Webinar
FDA Participant/Group: N/A
Non FDA Participant/Group: Attendees of the COVID-19 Vaccine Education and Equity Project/National Foundation for Infectious Diseases Webinar

Event Date: 10/12/2023
Location: Boston, MA
Subject: Abingworth Portfolio Showcase Meeting; Advancing Rare Disease Gene Therapy
FDA Participant/Group: N/A
Non FDA Participant/Group: Attendees of the Abingworth Portfolio Showcase Meeting

Event Date: 10/13/2023
Location: Philadelphia, PA
Subject: Penn Medicine Translational Neuroscience Center Neuro Gene Therapy Symposium; Facilitating the Development and Availability of Gene Therapy for Small Populations
FDA Participant/Group: N/A
Non FDA Participant/Group: Attendees of the Penn Medicine Translational Neuroscience Center Neuro Gene Therapy Symposium

Official Name: Jeffrey Shuren, M.D., J.D., Director, Center for Devices and Radiological Health

Event Date: 10/11/2023
Location: Anaheim, CA
Subject: AdvaMed MedTech Annual Conference: CDRH Town Hall
FDA Participant/Group: FELIPE AGUEL; SUZANNE SCHWARTZ; DOUGLAS KELLY; MICHELLE TARVER; TROY TAZBAZ;
Non FDA Participant/Group: Members of industry, government, academia, and other stakeholders

Official Name: Donald Prater, Acting Director, Center for Food Safety and Applied Nutrition

Event Date: 10/10/2023
Location: Virtual
Subject: Antimicrobial Resistance
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Ana Luisa Pereira Mateus, Andres Garcia Campos, Dante Mateo, Javier Yugueros-Marcos, Maria Szabo (World Organization for Animal Health (WOAH));

Event Date: 10/10/2023
Location: Virtual
Subject: Human Foods Program Follow-up Meeting
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Jennifer Trodden , Michele Sainato, Richard Ball (New York State Department of Agriculture);

Official Name: Brian King, Ph.D., Director, Center for Tobacco Products

No Significant Event

Official Name: Tracey H. Forfa, J.D., Director, Center for Veterinary Medicine

No Significant Event

Official Name: Tucker Patterson, Ph.D., Director, National Center for Toxicological Research

No Significant Event

Official Name: Mark Raza, J.D., Chief Counsel

No Significant Event

 

 
Back to Top